UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer

BMC cancer, 2023-12, Vol.23 (1), p.1222-1222, Article 1222

2023

Volltextzugriff (PDF)

Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy

Supportive care in cancer, 2018-02, Vol.26 (2), p.483-489

2018

Volltextzugriff (PDF)

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients

Gynecologic oncology, 2020-08, Vol.158 (2), p.431-439

2020

Volltextzugriff (PDF)

The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis

ESMO open, 2022-12, Vol.7 (6), p.100635, Article 100635

2022

Volltextzugriff (PDF)

Women’s responses and understanding of polygenic breast cancer risk information

Familial cancer, 2020-10, Vol.19 (4), p.297-306

2020

Volltextzugriff (PDF)

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer

European journal of human genetics : EJHG, 2016-11, Vol.24 (11), p.1517-1523

2016

Volltextzugriff (PDF)

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third‐party funding is unavailable

Asia-Pacific journal of clinical oncology, 2018-12, Vol.14 (6), p.410-416

2018

Volltextzugriff (PDF)

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Volltextzugriff (PDF)

465P Oncological care needs of people with mental illness: A single institution experience in Australia

Annals of oncology, 2023-11, Vol.34, p.S1643

2023

Volltextzugriff (PDF)

Rapid screening for depression - validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients

British journal of cancer, 2004-08, Vol.91 (5), p.900-906

2004

Volltextzugriff (PDF)

Abstract P6-14-07: Not presented

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-14-07

2019

Volltextzugriff (PDF)

16P Patient and healthcare practitioner preferences in early-stage triple-negative breast cancer treatment: A discrete choice experiment

Annals of oncology, 2023-11, Vol.34, p.S1472-S1473

2023

Volltextzugriff (PDF)

713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial

Annals of oncology, 2024-09, Vol.35, p.S546-S547

2024

Volltextzugriff (PDF)

23P Consensus statements and expert recommendations for BRCAm breast cancer in the Asia-Pacific region (STREAM-AP)

Annals of oncology, 2023-11, Vol.34, p.S1475-S1476

2023

Volltextzugriff (PDF)

747P SOLACE2: A phase II randomized trial of olaparib (O) and durvalumab (D) with or without low dose cyclophosphamide (LDCy) in platinum-sensitive recurrent ovarian cancer (PSROC)

Annals of oncology, 2024-09, Vol.35, p.S566-S567

2024

Volltextzugriff (PDF)

LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

Annals of oncology, 2023-10, Vol.34, p.S1281-S1282

2023

Volltextzugriff (PDF)

884TiP AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer

Annals of oncology, 2020-09, Vol.31, p.S647-S647

2020

Volltextzugriff (PDF)

13 Mucinous ovarian carcinoma: therapeutic options old and new

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A8-A8

2019

Volltextzugriff (PDF)

P644Changes in cardiopulmonary fitness and cardiac reserve 12-months following anthracycline-based chemotherapy with or without concurrent exercise training

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

Imatinib mesylate (STI571, Glivec)

Cancer forum, 2001-11, Vol.25 (3)

Y Antill

2001

Volltextzugriff (PDF)

35MO Quality-adjusted survival in patients with advanced or recurrent endometrial carcinoma treated with atezolizumab in combination with carboplatin-paclitaxel versus carboplatin-paclitaxel in the AtTEnd/ENGOT-EN7 trial

ESMO open, 2024-06, Vol.9, p.103535, Article 103535

2024

Volltextzugriff (PDF)

729 Exercise Training Attenuates Anthracycline-Induced Myocardial Injury in Early-Stage Breast Cancer Patients

Heart, lung & circulation, 2020, Vol.29, p.S364-S364

2020

Volltextzugriff (PDF)

286 Anthracycline Chemotherapy is not associated with Reductions in Right-Ventricular or Left Atrial Strain in Early-Stage Breast Cancer Patients

Heart, lung & circulation, 2020, Vol.29, p.S162-S162

2020

Volltextzugriff (PDF)

399 Reduced End Systolic Volume is associated With Attenuated Cardiac Reserve and Lower Exercise Capacity in Women Recently Diagnosed With Breast Cancer

Heart, lung & circulation, 2020, Vol.29, p.S217-S218

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer

Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients

The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis

Women’s responses and understanding of polygenic breast cancer risk information

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third‐party funding is unavailable

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

465P Oncological care needs of people with mental illness: A single institution experience in Australia

Rapid screening for depression - validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients

Abstract P6-14-07: Not presented

16P Patient and healthcare practitioner preferences in early-stage triple-negative breast cancer treatment: A discrete choice experiment

713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial

23P Consensus statements and expert recommendations for BRCAm breast cancer in the Asia-Pacific region (STREAM-AP)

793TiP A phase III, randomized, open-label, multicenter study of sacituzumab tirumotecan (sac-TMT) monotherapy vs treatment of physician’s choice chemotherapy in patients with endometrial cancer who have received prior chemotherapy and immunotherapy: ENGOT-en23/GOG-3095/MK-2870-005

747P SOLACE2: A phase II randomized trial of olaparib (O) and durvalumab (D) with or without low dose cyclophosphamide (LDCy) in platinum-sensitive recurrent ovarian cancer (PSROC)

LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

884TiP AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer

13 Mucinous ovarian carcinoma: therapeutic options old and new

P644Changes in cardiopulmonary fitness and cardiac reserve 12-months following anthracycline-based chemotherapy with or without concurrent exercise training

Imatinib mesylate (STI571, Glivec)

35MO Quality-adjusted survival in patients with advanced or recurrent endometrial carcinoma treated with atezolizumab in combination with carboplatin-paclitaxel versus carboplatin-paclitaxel in the AtTEnd/ENGOT-EN7 trial

729 Exercise Training Attenuates Anthracycline-Induced Myocardial Injury in Early-Stage Breast Cancer Patients

286 Anthracycline Chemotherapy is not associated with Reductions in Right-Ventricular or Left Atrial Strain in Early-Stage Breast Cancer Patients

399 Reduced End Systolic Volume is associated With Attenuated Cardiac Reserve and Lower Exercise Capacity in Women Recently Diagnosed With Breast Cancer

Suchergebnisse filtern